Suppr超能文献

通过在小鼠体内转导包含Pdx1、Ngn3、MafA的多顺反子构建体将胰腺腺泡细胞重编程为功能性β细胞

Reprogramming of Pancreatic Acinar Cells to Functional Beta Cells by In Vivo Transduction of a Polycistronic Construct Containing Pdx1, Ngn3, MafA in Mice.

作者信息

Cavelti-Weder C, Zumsteg A, Li W, Zhou Q

机构信息

Section on Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston.

University Hospital of Basel, Department of Endocrinology, Diabetes, and Metabolism, Basel, Switzerland.

出版信息

Curr Protoc Stem Cell Biol. 2017 Feb 2;40:4A.10.1-4A.10.12. doi: 10.1002/cpsc.21.

Abstract

To generate new beta cells after birth is a key focus of regenerative medicine, which could greatly aid the major health burden of diabetes. Beta-cell regeneration has been described using four different approaches: (1) the development of beta cells from putative precursor cells of the adult pancreas, which is termed neogenesis, (2) replication of existing beta cells, (3) differentiation from embryonic or induced pluripotent stem cells, and (4) reprogramming of non-beta cells to beta cells. Studies from the authors' laboratory have shown that beta-cell reprogramming can be achieved by transduction of adult pancreatic tissues with viral constructs containing the three developmentally important transcription factors Pdx1, Ngn3, and MafA. This protocol outlines the generation of a polycistronic construct containing the three transcription factors, the expansion and purification of the polycistronic virus, and in vivo transduction for acinar to beta-cell reprogramming in adult mice. The ultimate goal is to generate beta-like cells that resemble as closely as possible endogenous beta cells in phenotype and function for potential translational applications. © 2017 by John Wiley & Sons, Inc.

摘要

出生后生成新的β细胞是再生医学的一个关键重点,这可能极大地有助于减轻糖尿病带来的主要健康负担。β细胞再生已通过四种不同方法进行描述:(1)从成年胰腺的假定前体细胞发育β细胞,这被称为新生;(2)现有β细胞的复制;(3)从胚胎或诱导多能干细胞分化;(4)将非β细胞重编程为β细胞。作者实验室的研究表明,通过用含有三个对发育至关重要的转录因子Pdx1、Ngn3和MafA的病毒构建体转导成年胰腺组织,可以实现β细胞重编程。本方案概述了包含这三个转录因子的多顺反子构建体的生成、多顺反子病毒的扩增和纯化,以及在成年小鼠体内进行腺泡细胞到β细胞重编程的转导。最终目标是生成在表型和功能上尽可能类似于内源性β细胞的β样细胞,用于潜在的转化应用。© 2017约翰威立父子公司版权所有

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验